e1:compound
e2:bioact

alpha-amyrin;analgesic
alpha-amyrin;anti-inflammatory
alpha-amyrin cinnamate;anti-inflammatory activity
alpha-amyrin cinnamate;inhibitory effects on Epstein-Barr virus early antigen
beta-Amyrin;analgesic
beta-Amyrin;anti-fungal activity against a.rabiei
beta-Amyrin;anti-inflammatory
beta-amyrin cinnamate;anti-inflammatory activity
beta-amyrin cinnamate;inhibitory effects on Epstein-Barr virus early antigen
beta-Sitosterol;anti-proliferative
beta-Sitosterol;anti-proliferative
beta-Sitosterol;anti-proliferative
beta-Sitosterol;anti-proliferative
beta-Sitosterol;decrease cell viability
beta-Sitosterol;antioxidant
beta-Sitosterol;cytotoxic
beta-Sitosterol;cytotoxic
beta-Sitosterol;cytotoxic
beta-Sitosterol;growth inhibitory effect MDA- MB-231
beta-Sitosterol;growth inhibitory effect on MCF-7
beta-Sitosterol;inhibited the proliferation
beta-Sitosterol;inhibitor
beta-Sitosteryl-beta-D-Glucoside;antioxidant
Coenzyme Q10;anti-proliferative effects on breast cancer cells
Gaudichaudysolin a;HL60
Gaudichaudysolin a;cytotoxic
Gaudichaudysolin a;cytotoxic
Gaudichaudysolin a;cytotoxic
Gaudichaudysolin a;cytotoxic
Lupenone;adipocyte differentiatio
Lupeol;anti-fungal activity against fusarium oxysporum and penicillium notatum
Lupeol;anti-inflammatory
Lupeol;antiurolithiatic
Lupeol;diuretic
Lupeol;growth inhibition and apoptosis in SMMC7721
Lupeol;hypotensive
Lupeol;inhibited the proliferation of MDA-MB-231
Lupeol acetate;hypotensive
Lupeol cinnamate;anti-inflammatory activity
Lupeol cinnamate;inhibitory effect on skin tumor promotion
Lupeol cinnamate;inhibitory effects on Epstein-Barr virus early antigen
Polyprenol;anti-proliferative
Polyprenol;anti-proliferative
Polyprenol;anti-proliferative
Polyprenol;decrease cell viability
Polyprenol;antitumor
Polyprenol;cytotoxic
Polyprenol;cytotoxic
Polyprenol;cytotoxic
Polyprenol;hepatoprotective
Squalene;anti-proliferative
Squalene;anti-proliferative
Squalene;anti-proliferative
Squalene;decrease cell viability
Squalene;anti-proliferative effects on breast cancer cells
Squalene;antitumor
Squalene;control colonic aberrant crypt foci formation
Squalene;cytotoxic
Squalene;cytotoxic
Squalene;cytotoxic
Squalene;suppress colonic ACF formation and crypt multiplicity
Stigmasterol;anti-inflammatory
Stigmasterol;anti-proliferative
Stigmasterol;antimutagenic
Stigmasterol;antiosteoarthritic
Stigmasterol;antioxidant
Stigmasterol;cytostatic against hep-2
Stigmasterol;cytostatic against mccoy cells
Stigmasterol;inhibited tumour promotion in two stage carcinogenesis
Stigmasterol;therapeutic efficacy against Ehrlich
Tocotrienols;anti-proliferative effects on breast cancer cells
Triacylglycerols;decrease cell viability
Triacylglycerols;decrease cell viability MDA-MB-231
Triglycerides;anti-proliferative
Triglycerides;anti-proliferative
Triglycerides;anti-proliferative
Triglycerides;decrease cell viability
Triglycerides;cytotoxic
Triglycerides;cytotoxic
Triglycerides;cytotoxic
Ursolic acid;antioxidant
